GI
WINT

Gradient Investments’s Windtree Therapeutics Inc WINT Stock Holding History

Gradient Investments’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-714
Closed -$3K – 779
2015
Q3 		$3K Hold
714
– – ﹤0.01% 503
2015
Q2 		$7K Buy
+714
New +$10K ﹤0.01% 434

Other funds holding WINT

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Gradient Investments's WINT Position: Q4 2015 in Review

Gradient Investments sold out of Windtree Therapeutics Inc (WINT) in Q4 2015, closing a stake of 714 shares — an estimated $3K sold.

Gradient Investments first reported a position in WINT in Q2 2015 and held it in 2 quarters. The position peaked at $7K in Q2 2015. 53 funds tracked by Wall St. Rank hold WINT as of Q4 2015.

  • Gradient Investments reported no remaining Windtree Therapeutics Inc position as of Q4 2015 after selling out during the quarter.
  • Gradient Investments sold 714 Windtree Therapeutics Inc shares in Q4 2015, an estimated $3K.
  • Gradient Investments first reported a position in Windtree Therapeutics Inc in Q2 2015 and held it in 2 quarters.
  • Gradient Investments's Windtree Therapeutics Inc position peaked at $7K in Q2 2015.
  • 53 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q4 2015.

Based on Gradient Investments's 13F filing for Q4 2015, filed 19 Jan 2016.